He spent seven years fighting a bruising battle against a muscular and deep-pocketed opponent who clobbers the industry he represents.JC Scott describes the Pharmaceutical Care Management Association (PCMA) he led as a “scrappy” fighter that punches above its weight. That’s good because the $62 million-revenue organization, which represents pharmacy benefit management (PBM) companies, is up against the $483 million-revenue Pharmaceutical Research and Manufacturers of America (PhRMA), which represents drug companies.PhRMA is running an effective media campaign — its TV and online spots are ubiquitous in the Washington area — casting Scott’s members as “middlemen” who drive up drug costs.… Read More